期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
中性粒细胞明胶酶相关脂质运载蛋白对老年脓毒症心功能障碍的诊断和预后评估价值 被引量:1
1
作者 卞叶萍 邓晓静 +2 位作者 佘丽萍 程惠 徐剑 《实用老年医学》 CAS 2020年第9期937-939,943,共4页
目的探讨中性粒细胞明胶酶相关脂质运载蛋白(NGAL)对老年脓毒症心功能障碍的诊断及预后的评估价值。方法选择2016年6月至2019年6月南京医科大学附属老年医院ICU收治的老年脓毒症病人132例,所有病人于入院时抽取静脉血检测NGAL、BNP、肌... 目的探讨中性粒细胞明胶酶相关脂质运载蛋白(NGAL)对老年脓毒症心功能障碍的诊断及预后的评估价值。方法选择2016年6月至2019年6月南京医科大学附属老年医院ICU收治的老年脓毒症病人132例,所有病人于入院时抽取静脉血检测NGAL、BNP、肌钙蛋白(cTn)I、肌酸激酶同工酶MB(CK-MB)及肌红蛋白(Mb)。根据入院时LVEF将病人分为心功能障碍组(LVEF≤50%)54例和非心功能障碍组(LVEF>50%)78例,比较2组一般资料、NGAL、BNP、cTnI、CK-MB、Mb水平的差异;在脓毒症心功能障碍亚组中分析病人NGAL水平与LVEF、BNP、cTnI、CK-MB、Mb的相关性;根据28 d预后分为生存组及死亡组,比较不同预后病人间NGAL、LVEF、BNP、cTnI、CK-MB及Mb水平的差异。结果脓毒症心功能障碍组病人年龄、脓毒症相关序贯器官衰竭(SOFA)评分、BNP、cTnI、Mb及NGAL水平显著高于非心功能障碍组(P<0.05或P<0.01);脓毒症心功能障碍病人入院时的NGAL水平与LVEF呈负相关(r=-0.725,P<0.001),与BNP(r=0.432,P=0.001)、Mb(r=0.348,P=0.010)呈正相关。脓毒症心功能障碍死亡组的NGAL水平明显高于生存组(391.17±143.11)比(197.29±65.41)ng/mL,P<0.01。结论老年脓毒症病人发生心功能障碍时,NGAL水平明显升高,与传统诊断指标具有较高一致性,且在死亡病人中NGAL水平更高,提示NGAL对老年脓毒症心功能障碍的诊断及预后判断具有重要意义。 展开更多
关键词 脓毒症 心功能障碍标志物 诊断 预后
下载PDF
Multi-biomarker strategy for prediction of myocardial dysfunction and mortality in sepsis 被引量:8
2
作者 Fa-chao CHEN Yin-chuan XU Zhao-cai ZHANG 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2020年第7期537-548,共12页
Objective:The present study was to evaluate the feasibility of using the multi-biomarker strategy for the prediction of sepsis-induced myocardial dysfunction(SIMD)and mortality in septic patients.Methods:Brain natriur... Objective:The present study was to evaluate the feasibility of using the multi-biomarker strategy for the prediction of sepsis-induced myocardial dysfunction(SIMD)and mortality in septic patients.Methods:Brain natriuretic peptide(BNP),cardiac troponin I(cTnI),and heart-type fatty acid-binding protein(h-FABP)in 147 septic patients were assayed within 6 h after admission.We also determined the plasma levels of myeloperoxidase(MPO)and pregnancyassociated plasma protein-A(PAPP-A).The receiver operating characteristic(ROC)curve was used to assess the best cutoff values of various single-biomarkers for the diagnosis of SIMD and the prediction of mortality.Also,the ROC curve,net reclassification improvement(NRI),and integrated discrimination improvement(IDI)indices were used to evaluate the feasibility of using multi-biomarkers to predict SIMD and mortality.Results:Our statistics revealed that only h-FABP independently predicted SIMD(P<0.05).The addition of MPO and cTnI to h-FABP for SIMD prediction provided an NRI of 18.7%(P=0.025)and IDI of 3.3%(P=0.033).However,the addition of MPO or cTnI to h-FABP did not significantly improve the predictive ability of h-FABP to SIMD,as evidenced by the area under the curve(AUC),NRI,and IDI(all P>0.05).A history of shock and MPO were independent predictors of mortality in septic patients(both P<0.05).The addition of PAPP-A and h-FABP to MPO resulted in a mortality prediction with NRI of 25.5%(P=0.013)and IDI of 2.9%(P=0.045).However,this study revealed that the addition of h-FABP or PAPP-A to MPO did not significantly improve the ability to predict mortality,as evidenced by the AUC,NRI,and IDI(all P>0.05).Conclusions:The findings of this study indicate that a sensitive and specific strategy for early diagnosis of SIMD and mortality prediction in sepsis should incorporate three biomarkers. 展开更多
关键词 Multi-biomarker Myocardial dysfunction SEPSIS MORTALITY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部